Medtronic (NYSE:MDT) yesterday said it took out a stake with an option to buy on Arsenal Medical subsidiary Aresenal AAA and its hemostatic foam.* Arsenal AAA is developing the foam and a delivery system that are designed to reduce the chance of endoleaks after the placement of a stent graft to treat an abdominal aortic aneurysm. Financial terms […]
Medtronic
TAVI: Boston Scientific’s Lotus valve tops Medtronic’s CoreValve – study
Data from a study of Boston Scientific‘s (NYSE:BSX) Lotus Valve showed a greater device success rate than Medtronic‘s (NYSE:MDT) CoreValve in high-risk transcatheter aortic valve replacement patients. The single-center, non-randomized study, published this month in the journal JACC: Cardiovascular Interventions, compared outcomes from 50 high-risk TAVI patients treated with the Lotus valve and 50 similar patients treated with Medtronic’s self-expanding CoreValve […]
Diabetes: Medtronic furthers the quest for an artificial pancreas
Medtronic (NYSE:MDT) and Intarcia Therapeutics were in the spotlight at the American Diabetes Assn.’s annual scientific sessions conference in Boston last week, revealing new medical device developments in the fight against diabetes. Medtronic took center stage, announcing new developments for its artificial pancreas program, touting positive data from a user study of its MiniMed 640g and revealing plans to collaborate […]
Medtronic launches Fortrex PTA balloon catheter in US
Medtronic (NYSE:MDT) said yesterday that it launched its Fortrex percutaneous transluminal angioplasty balloon catheter in the U.S. The Fortrex is designed to treat peripheral artery disease and maintain arteriovenous access for hemodialysis, the Fridley, Minn.-based company said. The catheter uses a balloon to break up plaque blockages in the peripheral vascular system, or blockages in hemodialysis […]
Medtronic releases new bariatric surgery device
Medtronic (NYSE:MDT) said it launched the GastriSail, a new device designed to improve consistency and efficiency during sleeve gastrectomy procedures, in the U.S. Sleeve gastrectomies are the most popular weight loss procedures in the U.S. right now, GastriSail co-developer Dr. Amit Trivedi of the Hackensack University Medical Center in N.J. told MassDevice.com. Trivedi said he was inspired […]
Bayer sells Diabetes Care business to Panasonic Healthcare
(Reuters) — Bayer‘s (ETR:BAYN) has agreed to sell its Diabetes Care business to Panasonic Healthcare Holdings, backed by KKR (NYSE:KKR) and Panasonic (NYSE:PC), for 1.02 billion euros ($1.15 billion), the company said on Wednesday. The deal, expected to be completed in the first quarter of 2016, marks Bayer’s second attempt to divest the blood glucose monitoring […]
Diabetes: Medtronic partners with Samsung, Glooko; wins 510(k) for MiniMed Connect
Medtronic (NYSE:MDT) today announced a slew of developments from its diabetes treatment arm, including FDA clearance of its MiniMed Connect diabetes monitoring system; a partnership with Samsung Electronics (LON:BC94) to develop technology for diabetes management; and an agreement with diabetes-monitoring platform developer Glooko. The announcements were made at the American Diabetes Assn.’s annual meeting in Boston. […]
FLASH: Medtronic’s Q4 results top expectations
Medtronic (NYSE:MDT) today reported fiscal 4th-quarter results that beat Wall Street’s expectations on both the top and bottom lines, sending shares up in pre-market trading despite a slide into red ink. The Fridley, Minn.-based medical device giant posted a loss of -$1 million, or 0¢ per share, on sales growth of 60.0% to $7.30 billion […]
UPDATE – Insulin pump hacker outs Medtronic, company responds

The security expert who hacked his own insulin pump revealed that the device came from Medtronic Inc. (NYSE:MDT), and accused the med-tech giant of ignoring his warnings.
Today the Natick, Mass.-based med-tech giant posted its official response to the hullabaloo, writing that it takes device information security very seriously but sees malicious medical device hacking as a very low threat.